Literature DB >> 30710132

Unmasking cancer cell character.

M Teresa Villanueva1.   

Abstract

Entities:  

Keywords:  Cancer; Drug discovery; Therapeutics

Year:  2019        PMID: 30710132     DOI: 10.1038/d41573-019-00005-y

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.

Authors:  Jeffrey J Ishizuka; Robert T Manguso; Collins K Cheruiyot; Kevin Bi; Arpit Panda; Arvin Iracheta-Vellve; Brian C Miller; Peter P Du; Kathleen B Yates; Juan Dubrot; Ilana Buchumenski; Dawn E Comstock; Flavian D Brown; Austin Ayer; Ian C Kohnle; Hans W Pope; Margaret D Zimmer; Debattama R Sen; Sarah K Lane-Reticker; Emily J Robitschek; Gabriel K Griffin; Natalie B Collins; Adrienne H Long; John G Doench; David Kozono; Erez Y Levanon; W Nicholas Haining
Journal:  Nature       Date:  2018-12-17       Impact factor: 49.962

2.  Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss.

Authors:  Huayang Liu; Javad Golji; Lauren K Brodeur; Franklin S Chung; Julie T Chen; Rosalie S deBeaumont; Caroline P Bullock; Michael D Jones; Grainne Kerr; Li Li; Daniel P Rakiec; Michael R Schlabach; Sosathya Sovath; Joseph D Growney; Raymond A Pagliarini; David A Ruddy; Kenzie D MacIsaac; Joshua M Korn; E Robert McDonald
Journal:  Nat Med       Date:  2018-12-17       Impact factor: 53.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.